A newly developed assay may help investigators identify novel drug candidates to protect kidney cells and prevent or treat chronic kidney disease (CKD). The advance is described in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
CKD affects more than 13% of adults in the United States, with diabetes, hypertension and atherosclerosis being common risk factors. Most patients rely on antihypertensive medications for treatment, and there are no therapies available that directly and specifically target the kidney.
A team led by Vineet Gupta, PhD and Jochen Reiser, MD, PhD (Rush University Medical Center) has now developed a system that can be used to identify novel drug candidates that protect the function of kidney podocytes, cells that are critical for filtering the blood. Damage to these cells is a hallmark of CKD.
"A key barrier to the rational development of podocyte-directed therapeutics has been a lack of cell-based assays for use in high-throughput drug discovery environment," said Dr. Gupta. "Our report describes what we believe to be the first podocyte cell-based high content screening assay for the identification of novel podocyte-directed therapeutics in a high-throughput fashion."
Using the assay, which analyzes thousands of podocytes under different conditions in multi-well plates, the investigators identified 24 small molecules that protected podocytes against injury. When they treated mice and rats with one of the molecules, called pyrintegrin, the animals' podocytes remained healthy despite being exposed to damaging agents. Pyrintegrin activates β1 integrin, a protein that acts as a molecular bridge to help podocytes hold onto the outside of blood vessels and maintain the filtration apparatus in the kidney.
"We believe that this assay could provide the much needed boost in fueling the discovery and development of kidney directed therapeutics, development of which has significantly lacked in recent times," said Dr. Reiser.
Explore further: Chronic kidney disease may increase certain risks during pregnancy
More information: The article, entitled "A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules," will appear online at jasn.asnjournals.org/ on April 9, 2015.
Medical Xpress on facebook
Related Stories
Targeting certain kidney cells may help treat kidney failure
New research reveals that certain cells contribute to kidney function decline, making them attractive targets for treatments against kidney failure. The findings will appear in an upcoming issue of the Journal of the American So ...
Chronic kidney disease may increase certain risks during pregnancy
Even mild kidney disease during pregnancy may increase certain risks in the mother and baby, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings may ...
Blocking signal-transmitting cellular pores may prevent damage to kidneys
One of the most devastating side effects of diabetes is kidney failure, and one of the earliest signs of kidney damage is a disruption of the organ's filtering capacity. Diabetes patients who develop kidney failure must go ...
Low levels of circulating protein linked with heart problems in mice with kidney disease
Decreased blood levels of a kidney-derived protein called Klotho increases the risk of heart disease in mice with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of ...
Receptor protein appears to be key in breakdown of kidney filtration
Massachusetts General Hospital (MGH) researchers have identified a new molecular pathway that appears to be involved in urinary protein loss (proteinuria). This early-stage kidney disease affects 100 million people around ...
Recommended for you
Early physical therapy for low back pain reduces costs, resources
A study in the scientific journal BMC Health Services Research shows that early and guideline adherent physical therapy following an initial episode of acute, nonspecific low back pain (LBP) resulted in substantially lower ...
New Ebola study points to potential drug target
Opening the door to potential treatments for the deadly Ebola virus, scientists have found that a protein made by the virus plays a role similar to that of a coat-check attendant.
New evidence supports success of fecal transplants in treatment of Clostridium difficile infection
Research published in the open access journal Microbiome offers new evidence for the success of fecal microbial transplantation (FMT) in treating severe Clostridium difficile infection (CDI), a growing proble ...
Study tallies huge cost of hepatitis C drugs for RI prisons
A new study finds that effective new hepatitis C drugs are so expensive the state of Rhode Island would have to spend almost twice its entire prison health budget to treat all its chronically infected inmates. ...
Children with neurological disorders need flu vaccine but don't always get it
Children who have neurological disorders such as cerebral palsy or epilepsy are no more likely to be vaccinated against influenza than youngsters without these conditions, despite the increased risk for complications ...
Sabra recalls 30,000 cases of hummus over listeria concerns
About 30,000 cases of Sabra hummus sold nationwide is being recalled due to a possible Listeria contamination.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
A newly developed assay may help investigators identify novel drug candidates to protect kidney cells and prevent or treat chronic kidney disease (CKD). The advance is described in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
CKD affects more than 13% of adults in the United States, with diabetes, hypertension and atherosclerosis being common risk factors. Most patients rely on antihypertensive medications for treatment, and there are no therapies available that directly and specifically target the kidney.
A team led by Vineet Gupta, PhD and Jochen Reiser, MD, PhD (Rush University Medical Center) has now developed a system that can be used to identify novel drug candidates that protect the function of kidney podocytes, cells that are critical for filtering the blood. Damage to these cells is a hallmark of CKD.
"A key barrier to the rational development of podocyte-directed therapeutics has been a lack of cell-based assays for use in high-throughput drug discovery environment," said Dr. Gupta. "Our report describes what we believe to be the first podocyte cell-based high content screening assay for the identification of novel podocyte-directed therapeutics in a high-throughput fashion."
Using the assay, which analyzes thousands of podocytes under different conditions in multi-well plates, the investigators identified 24 small molecules that protected podocytes against injury. When they treated mice and rats with one of the molecules, called pyrintegrin, the animals' podocytes remained healthy despite being exposed to damaging agents. Pyrintegrin activates β1 integrin, a protein that acts as a molecular bridge to help podocytes hold onto the outside of blood vessels and maintain the filtration apparatus in the kidney.
"We believe that this assay could provide the much needed boost in fueling the discovery and development of kidney directed therapeutics, development of which has significantly lacked in recent times," said Dr. Reiser.
Explore further: Chronic kidney disease may increase certain risks during pregnancy
More information: The article, entitled "A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules," will appear online at jasn.asnjournals.org/ on April 9, 2015.
Medical Xpress on facebook
Related Stories
Targeting certain kidney cells may help treat kidney failure
New research reveals that certain cells contribute to kidney function decline, making them attractive targets for treatments against kidney failure. The findings will appear in an upcoming issue of the Journal of the American So ...
Chronic kidney disease may increase certain risks during pregnancy
Even mild kidney disease during pregnancy may increase certain risks in the mother and baby, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings may ...
Blocking signal-transmitting cellular pores may prevent damage to kidneys
One of the most devastating side effects of diabetes is kidney failure, and one of the earliest signs of kidney damage is a disruption of the organ's filtering capacity. Diabetes patients who develop kidney failure must go ...
Low levels of circulating protein linked with heart problems in mice with kidney disease
Decreased blood levels of a kidney-derived protein called Klotho increases the risk of heart disease in mice with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of ...
Receptor protein appears to be key in breakdown of kidney filtration
Massachusetts General Hospital (MGH) researchers have identified a new molecular pathway that appears to be involved in urinary protein loss (proteinuria). This early-stage kidney disease affects 100 million people around ...
Recommended for you
Early physical therapy for low back pain reduces costs, resources
A study in the scientific journal BMC Health Services Research shows that early and guideline adherent physical therapy following an initial episode of acute, nonspecific low back pain (LBP) resulted in substantially lower ...
New Ebola study points to potential drug target
Opening the door to potential treatments for the deadly Ebola virus, scientists have found that a protein made by the virus plays a role similar to that of a coat-check attendant.
New evidence supports success of fecal transplants in treatment of Clostridium difficile infection
Research published in the open access journal Microbiome offers new evidence for the success of fecal microbial transplantation (FMT) in treating severe Clostridium difficile infection (CDI), a growing proble ...
Study tallies huge cost of hepatitis C drugs for RI prisons
A new study finds that effective new hepatitis C drugs are so expensive the state of Rhode Island would have to spend almost twice its entire prison health budget to treat all its chronically infected inmates. ...
Children with neurological disorders need flu vaccine but don't always get it
Children who have neurological disorders such as cerebral palsy or epilepsy are no more likely to be vaccinated against influenza than youngsters without these conditions, despite the increased risk for complications ...
Sabra recalls 30,000 cases of hummus over listeria concerns
About 30,000 cases of Sabra hummus sold nationwide is being recalled due to a possible Listeria contamination.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
0 comments:
Post a Comment